Table_2_Deficiency of STING Promotes Collagen-Specific Antibody Production and B Cell Survival in Collagen-Induced Arthritis.DOCX
The levels of interferon-alpha are high in the serum and synovial fluid of rheumatoid arthritis (RA) patients. Activation of the stimulator of type I interferon genes (STING) mediates the productions of type I interferon and promotes chronic inflammation. STING plays a significant role in autoimmune lupus mice. However, the function of STING in collagen-induced arthritis (CIA) model has never been described. This study aimed to test the function of STING in CIA. The Sting-deficient mice developed arthritis comparable to WT mice. The levels of anti-collagen antibody from Sting-deficient mice were significantly higher than the WT mice. The B cells derived from Sting-deficient mice showed better survival than WT mice in response to the B cell receptor (BCR) stimulation. Activation of STING also induced B cell death, especially in activated B cells. This study demonstrated that the inhibition of STING promotes anti-collagen antibodies and B cell survival, which suggested that STING acts as a negative regulator of B cell function in the CIA model.
History
References
- https://doi.org//10.1001/jama.2018.13103
- https://doi.org//10.3904/kjim.2013.28.1.25
- https://doi.org//10.1038/nrdp.2018.1
- https://doi.org//10.1016/j.autrev.2019.05.007
- https://doi.org//10.3390/ijms20061332
- https://doi.org//10.1111/j.0105-2896.2009.00859.x
- https://doi.org//10.1038/nrrheum.2009.175
- https://doi.org//10.1038/nm.2050
- https://doi.org//10.1002/art.27653
- https://doi.org//10.3389/fmed.2018.00364
- https://doi.org//10.2217/imt-2018-0178
- https://doi.org//10.1038/nri3581
- https://doi.org//10.1136/annrheumdis-2012-202753
- https://doi.org//10.1136/ard.2006.063412
- https://doi.org//10.1002/eji.201040956
- https://doi.org//10.3109/08916930903510914
- https://doi.org//10.1038/nri3133
- https://doi.org//10.1038/416744a
- https://doi.org//10.1038/nri3921
- https://doi.org//10.1038/ni.2491
- https://doi.org//10.1093/jmcb/mjp048
- https://doi.org//10.1056/NEJMoa1312625
- https://doi.org//10.1073/pnas.1215006109
- https://doi.org//10.1073/pnas.1420217112
- https://doi.org//10.1128/IAI.00999-10
- https://doi.org//10.1038/nprot.2008.19
- https://doi.org//10.1074/mcp.RA118.000735
- https://doi.org//10.1186/ar2089
- https://doi.org//10.1089/jir.2011.0056
- https://doi.org//10.1046/j.1365-2567.2001.01257.x
- https://doi.org//10.1084/jem.20030896
- https://doi.org//10.1371/journal.pone.0060900
- https://doi.org//10.4049/jimmunol.1601999
- https://doi.org//10.1046/j.1365-2249.1998.00529.x
- https://doi.org//10.1186/ar1165
- https://doi.org//10.4049/jimmunol.1701405
- https://doi.org//10.14348/molcells.2015.2359
- https://doi.org//10.3389/fimmu.2018.00665
- https://doi.org//10.1016/j.immuni.2007.04.016
- https://doi.org//10.1158/0008-5472.CAN-15-1885
- https://doi.org//10.1038/nature08476
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity